Objective: To use the periosteum as a barrier in treatment of buccal Grade II furcation defects of lower molars.
Moreover, the animal studies and clinical trials have shown that the periosteum has the potential to stimulate bone formation when used as a graft or barrier membrane. Periosteum samples taken from the chick embryos have been demonstrated with an osteogenic capacity in vitro. [2] Free periosteal grafts taken from the tibia in the rabbits have shown the osteogenic potency when placed in the anterior chamber of the eye, in the capsule of the kidney, and in the donor site of the tibia. [3] Osteogenic and growth capacities of the free tibial periosteal graft in cleft lip and palate has been reviewed, and ossification of the periosteal graft has been confirmed. [4] Free autogenous periosteal graft taken from the palate has shown the evidence of defect fill and improvements in pocket depths in Class II furcation defects and interproximal bony defects, when placed as a barrier membrane. [5, 6] The use of the cultured periosteum taken from the mandibular body of adult hybrid dog has shown evidence of regenerating periodontal tissues in class II and class III furcation defects. [7] Case reports of periosteal displacement used a barrier in periradicular surgery have shown early remission of The evidence of effectiveness of guided tissue regeneration (GTR) for furcation defects have been reviewed systematically. GTR was consistently more effective than open flap debridement (OFD), reducing horizontal furcation depths, horizontal and vertical attachment levels and pocket depths for mandibular Class II furcation defects. However these improvements were modest and variable. [1] Periosteal membrane is an attractive alternative to existing barrier membrane since they are biologically accepted.
clinical signs and symptoms and successful healing. [8] A new technique of periosteoplasty (Periosteum eversion technique) was described by Gaggl et al. [9] In this technique, periosteal membrane was everted, and side opposite to cambium layer of periosteum is juxtaposed to recession area in the anterior teeth.
Our clinical study was undertaken to evaluate the efficacy of periosteal membrane as a barrier membrane in maintaining its vascular supply in buccal Grade II furcation defects in lower molars.
MATERIALS AND METHODS
The present study was powered to detect clinically significant difference (δ) in furcation defect fill of 0.5 mm horizontally using α = 0.05, a power = 80%, and a σ Of 0.53 mm obtained in a previous study from this group. [10] Calculations were performed using PS Power and Sample Size Calculation Software (version 3.0,January 2009 http://biostat.mc.vanderbilt.edu/twiki/bin/view/Main/ PowerSampleSize). A sample size of 11 pairs of patients was needed to accomplish the study. As my study design was through a split mouth approach using bilateral buccal grade II furcation defects, a single patient had both, a control site and an experimental site in this study design. Hence, 11 patients were needed to put the study in effect. 20 patients were assessed for eligibility. 12 patients were enrolled for the study. The study was conducted in 12 healthy subjects (7 male and 5 female) with a mean age of 37.5 ± 5.99 years (Range 28 to 49 years) [Chart 1 and Table 1 ]. Patients having at least one pair of bilateral buccal grade II furcation defects of lower molars were selected from outpatient department Chart 1: Consort flowchart of the study Inclusion criteria were as follows:
• Selected subjects were not under any medication during 1 st month before surgery.
• Periodontal probing depth (PPD) at mid furcation area was 5 mm or more.
• Third molars were excluded in the study.
• Patients had a good oral hygiene.
• Patients were free of any systemic disease.
Patients were enrolled in the study by Professor Saimbi C.S. who had verified the inclusion criteria and assigned the patients to treatment.
On a random basis, one furcation defect from each pair was selected for the control group and the opposite side furcation defect for the experimental group. Randomization was performed by allotting the left side selected furcation defect to the experimental group and the right side to the control group to 1 st enrolled patient, followed by just opposite to next enrolled patient. This alternate allotting was done to every next enrolled patient. Horizontal dimension of the furcation defect was the primary outcome measure. Gingival index, probing attachment level (PAL), and vertical dimension of furcation defect were the secondary outcome measures. Clinical parameters were registered at baseline and at 6 months by a blinded examiner.
Each patient was instructed about good oral hygiene practices, scaling and root planning was performed under local anesthesia, and occlusal adjustment was also done in selected patients requiring it. All patients achieved effective plaque control prior to entering the surgical phase. After this initial phase of treatment, the presurgical baseline soft tissue parameter, i.e, PAL, was measured with the standardized UNC-15 probe and a customized grooved acrylic stent. Gingival index (Loe and Silness, l963) [11] was also recorded for the facial aspect.
In both the groups, following local anesthesia, crevicular incisions were made starting one tooth distal to the tooth being treated, and extended a minimum of two teeth mesially. To gain adequate access, vertical releasing incisions were performed two teeth anterior to the tooth being treated. Full thickness mucoperiosteal flaps were reflected buccally. The granulation tissues were curetted out, and the exposed root surfaces were thoroughly planed. After debridement, the hard tissue parameters were registered with the UNC-15 probe. Vertical component of defect was measured from the cemento enamel junction (CEJ) to the deepest point of the vertical extent of the defect. Horizontal component of the furcation defect was measured from a probe tangential to the root surface, to the horizontal extent of the defect.
In the control group, the mucoperiosteal flaps were replaced without placement of any barrier membrane, and secured with interrupted interdental suturing using 3-0 black braided silk suture [Figures 1and 2] . In the experimental group, the osseous defects were completely covered by an autogenous periosteal membrane maintaining its vascular supply. The periosteal membranes were incised from the mucoperiosteal flap by two horizontal and one vertical incision below the mucogingival junction (MGJ). 1 st horizontal incision was given below the MGJ and mesial to the tooth being treated according to size of furcation defect of the tooth being treated, following which the periosteal membrane was dissected from the submucous connective tissue. 2 nd horizontal incision was given below and parallel to the 1 st horizontal incision. A vertical incision was then given mesial to the horizontal incisions to separate the periosteal membrane mesially, while the periosteal membrane remained attached distally maintaining its vascular supply. The periosteal membrane was mobilized and placed over the exposed furcation defect so that it covered at least 3 mm alveolar bone apical to the defect, and extended coronally at least 1 mm beyond the gingival margin of the flap. Periosteum contains two layer: An outer fibrous layer and an inner cambium layer, which is adjacent to bone. The periosteal membranes were placed such that the cambium layer juxtaposed to the exposed furcation and periosteal membranes were secured with absorbable 5-0 vicryl suture. The flaps were then sutured back as in the control group [ Figures 3-7] .
Periodontal dressings were given at a surgical site to cover the surgical areas. An antibiotic regimen of amoxicillin 500 mg thrice a day for 7 days and Nimesulide 100 mg twice daily for 5 days were prescribed. The patients were advised to rinse with 10 ml aqueous 0.2% solution of chlorhexidine gluconate for 1 minute twice a day and routine post-surgical instructions were given. After 1 week, the sutures and dressings were removed. Recall visits were carried out once every two weeks for 1 month following surgery and once every four weeks for the next two months. At these visits, oral hygiene instructions were reinforced and the areas were gently debrided.
At 6 months post -surgery, the soft tissue parameters were recorded in the same manner as before. The mucoperiosteal flaps were then reflected to repeat the hard tissue measurements. Flaps were then replaced and sutured, and antibiotics were prescribed for a period of 7 days and oral analgesics as needed. Statistical analysis was done on 'MSTAT' statistical analysis software. Significance of changes were tested by paired 't' test and changes among the groups were tested-by unpaired 't' test. Values are represented in Mean ± Standard deviation (SD).
RESULTS
At baseline, the mean PAL was 5.50 mm ± 0.80 for control group, and 5.33 mm ± 0.49 for experimental group [ Table 1 ]. After 6 months of treatment, the mean values were 4.67 mm ± 0.78 and 3.17 mm ± 0.39 for control group and experimental group respectively. On comparing the pretreatment values with post-treatment values, the gain in PAL were found to be statistically significant in both control ('P ' < 0.01) and experimental group ('P' < 0.001). On comparing both the groups, the mean gain in PAL was higher and also statistically significant in experimental group ('P ' < 0.001) [ Table 2 and Graph 1].
At baseline, the mean gingival index (GI) score was 1.67 ± 0.49 for the control group, and 1.58 ± 0.33 for the experimental group [ Table 1 ]. After 6 months of treatment, the mean values were 0.92 ± 0.33 for control group and 0.75 ± 0.30 for experimental group. On comparing the pre-treatment values with post-treatment values, the differences were found to be statistically significant for both groups ('P ' < 0.001). On comparing both groups the mean decrease in GI score was not found to be significant ('P ' = 0.35) [ Table 3 ].
At baseline, the mean vertical bone level was 6.67 mm ± 0.78 for control group and 7.83 mm ± 1.11 for experimental group [ Table 1 ]. After 6 months of treatment, the mean values were increased to 7.83 mm ± 6.72 for control group, while decreased to 6.17 mm ± 1.40 for experimental group. Control group showed significant ('P ' <0.001), mean loss of vertical bone level of 1.17 mm ± 0.39, while experimental group showed significant ('P ' <0.001) mean gain of vertical level of 1.67 mm + 0.49 [ Table 4 ].
At baseline, the mean horizontal bone level was 3.00 mm ± 0.00 for control group and 3.33 mm ± 0.78 for experimental group [ Table 1 ]. After 6 months of treatment, the mean values were reduced to 2.67 mm ± 0.49 and 1.83 ± 0.72 mm for control and experimental group respectively. Control group showed significant ('P ' < 0.05) mean defect fill of 0.33 mm ± 0.52, while experimental group showed significant ('P ' < 0.001) mean defect fill of 1.50 mm ± 0.55 [ Table 5 and Graph 2].
DISCUSSION
The present study showed significant gain in PAL and defect fill with the use of periosteal membrane as a barrier. These findings can be compared to observations made by Kwan et al. and Lekovic et al., utilizing periosteal graft as a barrier membrane in vertical and furcation defects, respectively. However, comparisons between the studies are difficult to make because of a number of differences in the study design. The measurements taken in this study were limited to the depth of furcation defects, and changes in the alveolar crest were not considered.
Hirata et al., described the ability of vascularized periosteum to form new bone. [12] Periosteum contains two distinct layers: A thick, outer fibrous layer and a thin inner cambium layer which is adjacent to bone. The cambium layer has the potential to stimulate the bone formation. [13] Hence, in the present study, the autogenous periosteal membrane was mobilized and placed over the
